aibioRCEL AVITA Medical, Inc.
AVITA Medical (RCEL) news
AVITA Medical, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker RCEL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest AVITA Medical news
We have not published a story on AVITA Medical yet. When there is news, it will appear here.
AVITA Medical annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $71.6 million | $64.3 million |
| Research and development | $20.8 million | $20.4 million |
| Net income (loss) | -$48.6 million | -$61.8 million |
| Cash from operations | -$31.2 million | -$48.9 million |
| Cash and equivalents | $10.2 million | $14.1 million |
| Short-term investments | $7.9 million | $21.8 million |
Questions about AVITA Medical
What is the ticker symbol of AVITA Medical?
AVITA Medical, Inc. trades under the ticker RCEL on NASDAQ.
Where is AVITA Medical listed?
AVITA Medical, Inc. is listed on NASDAQ.
Which country or territory is AVITA Medical listed under?
Our directory records AVITA Medical, Inc. under United States.
Does aibio.space cover AVITA Medical?
aibio.space lists AVITA Medical, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
What was AVITA Medical's revenue last year?
$71.6 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is AVITA Medical profitable?
AVITA Medical, Inc. reported a net loss of $48.6 million for the fiscal year ended Dec 31, 2025, and used $31.2 million of cash in operations, per its annual report to the SEC.
How much does AVITA Medical spend on research and development?
$20.8 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does AVITA Medical have?
$11.1 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
Investor discussion: AVITA Medical
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Financings
Filed a final prospectus for a securities offering. SEC Form 424B5. Source
Stock chart
Listing details
- Company
- AVITA Medical, Inc.
- Ticker
- RCEL
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction